Clinical Trial Update: Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating leflunomide in combination with steroids for acute graft-versus-host disease after donor stem cell transplantation in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancies

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Graft Versus Host Disease, Hematopoietic and Lymphoid System Neoplasm | Phase 1 | Status: RECRUITING